REG - CAP-XX Limited - Change of Board Structure and Grant of Options

CAP-XXAnnouncement

19/03/2025 07:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250319:nRSS2037Ba&default-theme=true

RNS Number : 2037B  CAP-XX Limited  19 March 2025

19 March 2025

CAP-XX Limited

Dr. Graham Cooley appointed as Chairman

Grant of options

CAP-XX Limited (LON: CPX), a global leader in the design and manufacture of
supercapacitors and energy management systems, announces a change to the
structure of its Board of Directors.

After more than 12 years of service as Chairman, Pat Elliott has stepped down
from that role but will remain as a Non-Executive Director. Dr. Graham Cooley,
who has been a Non-Executive Director since June 2024, has assumed the role of
Chairman.

This change reflects CAP-XX's decision to align the Board's leadership more
closely with the Company's need for engagement with its shareholders. Dr.
Cooley, who has extensive experience in the clean energy and advanced
technology sectors, is based in the UK and will look to enhance communication
and collaboration with investors and key stakeholders.

As part of his appointment as Chairman, Dr. Cooley has been granted 40,000,000
options (the "Options") over ordinary shares in the Company ("Ordinary
Shares"), to further align his interests with those of shareholders as CAP-XX
pursues its strategic objectives. The Options have an exercise price of 0.13p,
being the closing mid-market price of an Ordinary share on 18 March 2025, the
last practicable date prior to the grant of the Options. The five year options
will vest immediately. Following this grant of Options, the total number of
options outstanding over Ordinary Shares in the Company will be 264,165,000.

Pat Elliott commented: "It has been a tremendous privilege to serve as
Chairman of CAP-XX for over a decade, guiding the Company through many phases
of development. I am incredibly proud of what the team has accomplished and
have every confidence that Graham's leadership will support our continued
growth and success. I look forward to continuing to contribute as a
Non-Executive Director."

Dr. Graham Cooley added: "I would like to sincerely thank Pat for his
long-standing leadership and unwavering commitment to CAP-XX. His guidance has
been instrumental in shaping the Company into the innovative business it is
today. I am delighted to take on the role of Chairman and look forward to
working with our CEO Lars Stegmann, the Board and management team to drive
CAP-XX forward."

The FCA notification, made in accordance with the requirements of the UK
Market Abuse Regulation, is appended further below.

 

For further information contact:

 

CAP-XX Limited

Dr. Graham Cooley
(Chairman)
+61 (2) 9157 0000

Lars Stegmann (Chief Executive Officer)

 

Allenby Capital (Nominated Adviser and Broker)

David Hart / Piers Shimwell (Corporate Finance)
                        +44 (0) 20 3328 5656

Jos Pinnington / Tony Quirke (Sales and Corporate Broking)

 

Notes to Editors:

 

About CAP-XX

 

CAP-XX (LSE: CPX) is a leader in the design and manufacture of thin, flat
supercapacitors and energy management systems used in portable and small-scale
electronic devices, and to an increasing extent, in larger applications such
as automotive and renewable energy. The unique feature of CAP-XX
supercapacitors is their very high-power density and high energy storage
capacity in a space-efficient prismatic package. These attributes are
essential in power-hungry consumer and industrial electronics and deliver
similar benefits in automotive and other transportation applications.

 

For more information visit www.cap-xx.com (http://www.cap-xx.com)

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.

 1.  Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Dr Graham Cooley
 2.  Reason for the Notification
 a)  Position/status                                              Chairman
 b)  Initial notification/Amendment                               Initial Notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         CAP-XX Limited
 b)  LEI                                                          213800HECUSIYXH3WN26
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the Financial instrument, type of instrument  Ordinary shares of no par value each
     Identification code                                          ISIN: AU0000XINAS1
 b)  Nature of the transaction                                    Grant of options
 c)  Price(s) and volume(s)                                       Exercise Price(s)     Volume(s)
                                                                  0.13 pence per share  40,000,000
 d)  Aggregated information:                                      n/a

     -Aggregated volume

     -Price
 e)  Date of the transaction                                      18 March 2025
 f)  Place of the transaction                                     Outside of a trading venue

d)

Aggregated information:

-Aggregated volume

-Price

n/a

e)

Date of the transaction

18 March 2025

f)

Place of the transaction

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAJPMTTMTTBTJA